StonvexLoading…
StonvexStonvexStonvexCore line items from LMAT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 |
|---|---|---|---|---|---|
Revenue | $72.90M | $249.60M | $219.86M | $164.15M | $109.33M |
Operating Income | Not available | $67.91M | $52.26M | $39.40M | $26.25M |
Net Income | Not available | $57.73M | $44.04M | $32.85M | $11.83M |
EPS (Diluted) | $0.83 | $2.52 | $1.93 | $1.45 | $0.96 |
Total Assets | Not available | $615.69M | $551.82M | $377.02M | $363.08M |
Total Liabilities | Not available | $222.17M | $214.53M | $45.95M | $43.55M |
Cash & Equivalents | Not available | $28.24M | $25.61M | $21.00M | $22.27M |
Free Cash Flow OCF − CapEx | Not available | $74.47M | $37.16M | $24.02M | $11.45M |
Shares Outstanding | Not available | 22.77M | 22.55M | 22.72M | 22.66M |